Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
90.2M
-
Shares change
-
+6.34M
-
Total reported value, excl. options
-
$419M
-
Value change
-
+$25.3M
-
Put/Call ratio
-
0.5
-
Number of buys
-
97
-
Number of sells
-
-80
-
Price
-
$4.65
Significant Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q4 2021
252 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - COMMON STOCK as of Q4 2021.
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.2M shares
.
Largest 10 shareholders include BlackRock Inc. (21.8M shares), VANGUARD GROUP INC (15.7M shares), STATE STREET CORP (14.6M shares), GEODE CAPITAL MANAGEMENT, LLC (5.3M shares), JPMORGAN CHASE & CO (3.57M shares), NORTHERN TRUST CORP (2.95M shares), D. E. Shaw & Co., Inc. (2.45M shares), SABBY MANAGEMENT, LLC (2.19M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (2.14M shares), and Mirae Asset Global Investments Co., Ltd. (1.06M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.